Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Plos One|October 26, 2021
Multiparametric MRI for assessment of early response to neoadjuvant sunitinib in renal cell carcinomaStephan Ursprung, Andrew N Priest, Fulvio Zaccagna, et al.
European Urology Oncology|January 21, 2020
Deferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor-targeted Therapy in Patients with Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial DataRoderick de Bruijn, Akhila Wimalasingham, Bernadett Szabados, et al.
Kidney Cancer (Clifton, Va.)|October 10, 2022
A Systematic Review of Immune Checkpoint Inhibitors in Non-Clear-Cell Renal CancerAna Filipa Palma Dos Reis, Diana Simão, Thomas Odeny, et al.
European Urology Focus|September 19, 2019
A Decision Analysis Evaluating Screening for Kidney Cancer Using Focused Renal UltrasoundSabrina H Rossi, Tobias Klatte, Juliet A Usher-Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2022
A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell CarcinomaMartin H Voss, Arun A Azad, Aaron R Hansen, et al.
Biomarker Research|November 21, 2017
Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patientsSu Yin Lim, Jenny H Lee, Sarah J Welsh, et al.
JHEP Reports : Innovation in Hepatology|September 20, 2023
Incidence, risk factors and outcomes of checkpoint inhibitor-induced liver injury: A 10-year real-world retrospective cohort studyEdmond Atallah, Sarah J Welsh, Brent O'Carrigan, et al.
The New England Journal of Medicine|November 24, 2021
Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau DiseaseEric Jonasch, Frede Donskov, Othon Iliopoulos, et al.
BMC Cancer|January 25, 2022
The MITRE trial protocol: a study to evaluate the microbiome as a biomarker of efficacy and toxicity in cancer patients receiving immune checkpoint inhibitor therapyNicola A Thompson, Grant D Stewart, Sarah J Welsh, et al.
Biology|April 11, 2020
The Efficacy of Sunitinib Treatment of Renal Cancer Cells Is Associated with the Protein PHAX In VitroRafia S Al-Lamki, Nicholas J Hudson, John R Bradley, et al.
Pageof 5